Dionysis Douroumis

Biography

Dr. Douroumis obtained his Diploma in Chemistry and PhD from the Department of Pharmacy at Patras University in Greece. He studied the development of electroanalytical techniques for in situ monitoring of drug release from liposomal formulations. He worked as a postdoc fellow (2004) at the Friedrich–Schiller University of Jena, Department of Pharmacy with Professor Alfred Fahr. He studied the development of parenteral formulations of antiepileptic drugs (post funded by Novartis Pharma, Basel).

After the completion of this project he worked as a Team Leader (2005) again with Professor Fahr in the development of nano – liposomal formulations and treatment of Rheumatoid Arthritis by applying Photodynamic Therapy (post funded by Biolitec Pharma GmbH).

Following this, he worked for Phoqus Pharmaceutical plc as a Senior Scientist (2005) at the Product Development Department. His main tasks were the development of sustained/pulsatile release formulations, fast disintegrating dosage forms (FDDF) and taste masking of bitter drugs, also focussing on the development of coated coronary stents (Cypher) using a novel electrostatic dry powder deposition technology (EDPDT).

Dr. Douroumis joined the School of Sciences at Greenwich University in November 2007, gaining a Postgraduate Certificate in Higher Education (PGCert), from the School of Education, University of Greenwich in 2008.

He is a member of the Journal of Nanomedicine and Nanoscience (JNMNT), Omics Publishing Group Editorial Board, and a member of the following Societies:

• The Higher Education academy (UK)
• Academy of Pharmaceutical Sciences (APS – UK)
• Phospholipid Research Centre (Lipoid, Germany)
• Greek Chemists Association (Greece)

• Accessibility  |
• FOI   |
• Site Map  |
• Search  |
• Printable Page

• Student & Staff Portal  |
• Staff Intranet